BACKGROUND: Here, we described the presence of a neurotoxin with phospholipase A2 activity isolated from Micrurus lemniscatus venom (Mlx-8) with affinity for muscarinic acetylcholine receptors (mAChRs). METHODS: The purification, molecular mass determination, partial amino acid sequencing, phospholipase A2 activity determination, inhibition of the binding of the selective muscarinic ligand [3H]QNB and inhibition of the total [3H]inositol phosphate accumulation in rat hippocampus of the Mlx-8 were determined. RESULTS: Thirty-one fractions were collected from HPLC chromatography, and the Mlx-8 toxin was used in this work. The molecular mass of Mlx-8 is 13.628 Da. Edman degradation yielded the following sequence: NLYQFKNMIQCTNTRSWL-DFADYG-CYCGRGGSGT. The Mlx-8 had phospholipase A2 enzymatic activity. The pKi values were determined for Mlx-8 toxin and the M1 selective muscarinic antagonist pirenzepine in hippocampus membranes via [3H]QNB competition binding assays. The pKi values obtained from the analysis of Mlx-8 and pirenzepine displacement curves were 7.32 ± 0.15, n = 4 and 5.84 ± 0.18, n = 4, respectively. These results indicate that Mlx-8 has affinity for mAChRs. There was no effect on the inhibition ability of the [3H]QNB binding in hippocampus membranes when 1 µM Mlx-8 was incubated with 200 µM DEDA, an inhibitor of phospholipase A2. This suggests that the inhibition of the phospholipase A2 activity of the venom did not alter its ability to bind to displace [3H]QNB binding. In addition, the Mlx-8 toxin caused a blockade of 43.31 ± 8.86%, n = 3 and 97.42 ± 2.02%, n = 3 for 0.1 and 1 µM Mlx-8, respectively, on the total [3H]inositol phosphate content induced by 10 µM carbachol. This suggests that Mlx-8 inhibits the intracellular signaling pathway linked to activation of mAChRs in hippocampus. CONCLUSION: The results of the present work show, for the first time, that muscarinic receptors are also affected by the Mlx-8 toxin, a muscarinic ligand with phospholipase A2 characteristics, obtained from the venom of the Elapidae snake Micrurus lemniscatus, since this toxin was able to compete with muscarinic ligand [3H]QNB in hippocampus of rats. In addition, Mlx-8 also blocked the accumulation of total [3H]inositol phosphate induced by muscarinic agonist carbachol. Thus, Mlx-8 may be a new pharmacological tool for examining muscarinic cholinergic function.
BACKGROUND: Here, we described the presence of a neurotoxin with phospholipase A2 activity isolated from Micrurus lemniscatus venom (Mlx-8) with affinity for muscarinic acetylcholine receptors (mAChRs). METHODS: The purification, molecular mass determination, partial amino acid sequencing, phospholipase A2 activity determination, inhibition of the binding of the selective muscarinic ligand [3H]QNB and inhibition of the total [3H]inositol phosphate accumulation in rat hippocampus of the Mlx-8 were determined. RESULTS: Thirty-one fractions were collected from HPLC chromatography, and the Mlx-8 toxin was used in this work. The molecular mass of Mlx-8 is 13.628 Da. Edman degradation yielded the following sequence: NLYQFKNMIQCTNTRSWL-DFADYG-CYCGRGGSGT. The Mlx-8 had phospholipase A2 enzymatic activity. The pKi values were determined for Mlx-8 toxin and the M1 selective muscarinic antagonist pirenzepine in hippocampus membranes via [3H]QNB competition binding assays. The pKi values obtained from the analysis of Mlx-8 and pirenzepine displacement curves were 7.32 ± 0.15, n = 4 and 5.84 ± 0.18, n = 4, respectively. These results indicate that Mlx-8 has affinity for mAChRs. There was no effect on the inhibition ability of the [3H]QNB binding in hippocampus membranes when 1 µM Mlx-8 was incubated with 200 µM DEDA, an inhibitor of phospholipase A2. This suggests that the inhibition of the phospholipase A2 activity of the venom did not alter its ability to bind to displace [3H]QNB binding. In addition, the Mlx-8 toxin caused a blockade of 43.31 ± 8.86%, n = 3 and 97.42 ± 2.02%, n = 3 for 0.1 and 1 µM Mlx-8, respectively, on the total [3H]inositol phosphate content induced by 10 µM carbachol. This suggests that Mlx-8 inhibits the intracellular signaling pathway linked to activation of mAChRs in hippocampus. CONCLUSION: The results of the present work show, for the first time, that muscarinic receptors are also affected by the Mlx-8 toxin, a muscarinic ligand with phospholipase A2 characteristics, obtained from the venom of the Elapidae snake Micrurus lemniscatus, since this toxin was able to compete with muscarinic ligand [3H]QNB in hippocampus of rats. In addition, Mlx-8 also blocked the accumulation of total [3H]inositol phosphate induced by muscarinic agonist carbachol. Thus, Mlx-8 may be a new pharmacological tool for examining muscarinic cholinergic function.
In the Americas, the Elapidae family is represented by coralsnakes that comprise 120
species and subspecies belonging to the genera Micruroides,
Leptomicrurus and Micrurus [1, 2].
Micrurus is the most abundant and diverse genus with many
species found in South and Central America and the Southern United States [3-6].
However, the biochemistry and pharmacology of components from coralsnake venoms have
not yet been thoroughly studied.Currently, Micrurus lemniscatus is a species composed of three
subspecies (M. l. carvalhoi, M. l. helleri and
M. l. lemniscatus). Particularly, M. l.
carvalhoi is distributed along the Brazilian east coast from the
northeast to southeast of the country and in parts of central, central-western,
southeastern and southern Brazil, as well as eastern Paraguay and northeastern
Argentina [7, 8]. Moreover, the venom of this animal is composed of approximately 70%
three-finger toxins (3FTxs) and 10% phospholipase A2 (PLA2)
toxins [9]. While enzymatic toxins contribute
mainly to slow immobilization and digestion of prey, the non-enzymatic toxins
stimulate rapid immobilization through their neurotoxic or cardiotoxic effects
[10].In the elapid envenomation the presynaptic neurotoxins or β-neurotoxins and
postsynaptic neurotoxins or (-neurotoxins are recognized as major and most important
components of these venoms [11-13]. β-neurotoxins are characterized by their
PLA2 activity while (-neurotoxins can be characterized as 3FTx
enzymatic-free proteins that interact with cholinergic nicotinic receptors and
others that interact with muscarinic acetylcholine receptors (mAChRs).Secreted PLA2, found in mammals and animal venoms, have a molecular weight
between 12 and 19 kDa, have five to eight disulfide bridges and need millimolar
calcium concentrations for its catalytic activity [14]. Among the main components of animal venoms are the secreted PLA₂
that belong to distinct PLA₂s groups. Snake venom PLA₂s from Elapidae and Viperidae
families belong, respectively, to the IA and IIA/IIB groups [15, 16]. For instance,
snake venoms are rich sources of PLA2 enzymes that are frequently found
as a large number of isozymes [17].Based in transcriptomic data it can be observed that Micrurus
species are arranged in an approximately northwestern to southeastern sequence, the
high PLA2 and low 3FTx concentrations in the North to high 3FTx and low
PLA2 concentration in the South [9]. In this way, the proteomics of the Micrurus venoms
present a great diversity concerning the PLA2 composition. M.
surinamensis and M. l. carvalhoi venoms show relatively little
PLA2 activity. However, activity does not necessarily reflect the
amount of PLA2 present. Structure determination of new micrurine
PLA2 illustrates their great structural diversity. Of 121
PLA2s with partial or complete structures, the majority are
apparently catalytic, having the requisite H48, D49, Y52, and D101 in their active
sites. The remains are apparently non-catalytic [see 9, for review].Quantitative differences in the content of 3FTx and PLA2 might reflect
directly in the pharmacological and biological activities of
Micrurus venoms. On the other hand, Tanaka et al. [12] showed that M. frontalis, M.
ibiboboca and M. lemniscatus venoms contain different levels of
PLA2 activity, although the venom of M. frontalis
seems to have a lower hydrolytic activity when compared to M. lemniscatus
and M. ibiboboca venoms.Ciscotto et al. [17] identified that most
proteins (12-14 kDa) that were found are similar to PLA2 and indicated
the presence of both acidic and basic PLA2 in M. frontalis, M.
ibiboboca, M. lemniscatus and M. spixii. In general, basic
PLA2 enzymes are more toxic and exhibit higher pharmacological
potency than their neutral and acidic counterparts, being the basic residues
responsible for such potency and lethality [18]. Aside from displaying enzymatic activities, some vPLA2
possess a wide range of toxic effects, including neurotoxicity, myotoxicity,
cardiotoxicity, cytotoxicity, and may provoke convulsion and hypotension or affect
blood coagulation and platelet aggregation [17].Toxins from Elapid snake venoms play an important role in the characterization and
function of mAChRs in muscle and in the identification of muscarinic and nicotinic
subtypes of receptors in the central and peripheral nervous system. The venom of
Elapid snakes of the genus Dendroaspis (mambas) and
Naja contain 3FTx muscarinic neurotoxins with activity in
mAChRs. Moreover, these have a high affinity for a specific receptor subtype. In
addition, muscarinic toxins isolated from these venoms with agonist and antagonist
features have also been described [19-25]. In this way, we previously characterized
the biochemical and pharmacological features of a 3FTx, MT-Mlα, isolated from
Micrurus lemmiscatus venom. This toxin could displace the
binding of the selective muscarinic ligand [3H]quinuclidinyl benzilate
([3H]QNB) in rat hippocampus. Furthermore, studying pathways of
second messengers that can be involved in the effects of the MT-Mlα, our results
demonstrated that this toxin inhibited the total [3H]inositol phosphate
accumulation induced by muscarinic agonist carbachol [26].A new class of muscarinic neurotoxins has also been described. Thus, elapid
PLA2 neurotoxins isolated from Naja naja sputatrix
[27, 28] and Naja atra [29] venoms have a muscarinic inhibitor activity. In addition, previously
studies from our laboratory showed the neurotoxicity of four PLA2 (Mlx-8,
9, 11, and 12) isolated from the elapid Micrurus lemniscatus snake
venom after microinjection into the brain [30]. Those studies showed the presence of isolated and clustered spikes on
EEG records. These behavioral alterations were characterized mainly by forelimb
clonus, compulsive scratching, and severe neuronal damage. A recent study
investigated in detail the neurotoxic effects of two PLA2 toxins (Mlx-8
and Mlx-9) isolated from Micrurus lemniscatus venom on cultured
primary hippocampal neurons. These data demonstrated that the PLA2 toxins
Mlx-8 and Mlx-9 induce an early increase in free cytosolic calcium concentration and
mitochondrial function impairment, which would lead to structural changes and could
explain the toxicity to hippocampal neurons. Furthermore, the morphological
approaches showed features of hybrid cell death with apoptotic, autophagic, and
necrotic signs [15]. Interestingly, a recent
isoform of the Mlx-8 toxin named Lemnitoxin has PLA2 activity was also
isolated from Micrurus lemniscatus venom. This was cytotoxic to
differentiated myotubes in vitro and muscle fibers in
vivo. A pro-inflammatory activity was also described [31].We have launched a search for components associated with mAChRs in the venom of the
Brazilian snake Micrurus lemniscatus. We examined different peaks
isolated from this venom (named earlier Mlx-1, Mlx-2, Mlx-3, Mlx-4, Mlx-5, MT-Mlα
and Mlx-8). These were obtained from the analytical RP-HPLC profile of
Micrurus lemniscatus venom on a C8 column. The components were
also examined for their ability to compete with [3H]QNB for its binding
sites. However, only MT-Mlα (a 3FTx; [26])
and Mlx-8 (a PLA2-neurotoxin; unpublished data) could displace the
binding of the muscarinic ligand. In addition, partial amino acid sequences were
determined for MT-Mlα [26] and Mlx-8
(unpublished data). Based on these previous results, the present study investigated
the biochemical and pharmacological features of Mlx-8 isolated from Micrurus
lemniscatus venom with affinity for mAChRs. Thus, this work describes
the purification, molecular mass determination, partial amino acid sequencing, and
phospholipase A2 activity determination of Mlx-8. Furthermore, we
characterize its effects on the inhibition of the binding of the selective
muscarinic ligand [3H]QNB as well as inhibition of the total
[3H]inositol phosphate accumulation in male rat hippocampus.
Methods
Venom
Micrurus lemniscatus crude venom was obtained from the
Laboratory of Herpetology, Butantan Institute, São Paulo, Brazil. The venom was
a pool of several specimens collected in the Southeast region of Brazil. It was
lyophilized and stored dry at -20°C until use.
Animals
The conduct and procedures involving animal experiments were approved by the
Butantan Institute Committee for Ethics in Animal Experiments (license number
CEUAIB 1100/13) in compliance with the recommendations of the National Council
for the Control of Animal Experimentation of Brazil (CONCEA). All efforts were
made to minimize animal suffering.Male Wistar rats (90 day old; 324.8 ± 3.1 g, n = 52), coming from the Central
Animal Laboratory of the Butantan Institute, were housed in a polypropylene box
(inside length × width × height = 56 cm × 35 cm × 19 cm) (5 animals/cage
containing wood shavings) within a ventilated container (Alesco Ind. Com Ltda,
Brazil) under controlled temperature (23 ± 2oC), relative humidity
(65 ± 1%) and 12-h light/12-h dark cycle (lights on at 6:00 a.m.). The animals
were allowed to feed and to drink water ad libitum.
Drugs and Radiochemicals
Carbachol (carbamylcholine chloride), lithium chloride, myo-inositol, pirenzepine
(pirenzepine hydrochloride), HPLC grade acetonitrile, and trifluoroacetic acid
were obtained from Sigma Chemical Co. (USA). The 7,7-dimethyl-5,8-eicosadienoic
acid (DEDA) was obtained from Abcam Laboratories (USA). The
[3H]quinuclidinyl benzylate (specific activity 47 Ci/mmol) was
obtained from New England Nuclear (USA). Myo-[1,2-3H] inositol
(specific activity 18 Ci/mmol) was purchased from Amersham (UK). The OptiPhase
HiSafe 3 was obtained from Perkin Elmer (UK). The AG( 1-X8 (200 - 400
mesh) resin was purchased from Bio Rad Laboratories (Richmond, CA, USA). All
other drugs and reagents were obtained from Merck (Darmstadt, Germany) or Sigma
Chemical Co.
RP-HPLC Purification of
Micrurus lemniscatus crude venom (30 mg) was diluted in 3 mL of
Milli-Q water and purified as described by da Silva et al. [26]. Briefly, after filtration in a 0.45-μm
filter (Millipore), 800-μL samples (400 μg) were applied to a C8 reversed-phase
column (Shim-Pack; 4.6 mm× 250 mm, 5-μm particle) coupled to a HP 1100 series
HPLC system. The elution used a flow rate of 1 mL.min-1, and this was
monitored at 214 nm. The proteins were eluted with a linear gradient of
trifluoroacetic acid (TFA) (solvent A) (0.1% TFA in water) and acetonitrile
(solvent B) (90% acetonitrile + 10% A) from 10% to 35% of B over 80 min.
Thirty-one fractions were manually collected according to their absorbance.
Fractions that contained the Mlx-8 were purified in a C18 RP-HPLC column
(SUPELCOSIL-LC-18-DB 15 cm × 4.6 mm cat. no. 58348) eluted with a gradient of 0
to 90% acetonitrile (ACN JT Baker) containing 0.1% of TFA. Solvent A was 0.1%
TFA (in Milli-Q water), and solvent B was 90% ACN with 0.1% TFA. The purified
Mlx-8 toxin was assayed for its ability to inhibit the binding of selective
muscarinic ligand [3H]QNB. Moreover, the total
[3H]inositol phosphate was also determined for pharmacological
performance.
Mass Spectrometry
The samples were mixed in a saturated aqueous solution containing sulfuric acid
(1:1 v/v) and synergistic acid (90% of 2,5-dihydroxybenzoic acid and 10% of
α-cyano-4-hydroxycarnamic acid) as described by da Silva et al. [26]. Briefly, a cation exchange step was
added immediately before the analysis on an AnchorChip 600/384 MTP plates. This
was co-crystallized at ambient temperature, and the samples were processed with
reagents from Sigma-Aldrich (USA). The α-cyano-4-hydroxycinnamic acid MALDI
matrix was processed with Millipore® C18 Ziptips. MALDI-TOF mass spectrometry
was performed on an Axima Performance MALDI-TOF/TOF (Shimadzu, Japan) using an
α-cyano-4-hydroxycinnamic acid as the matrix. The peptide profile was acquired
in linear mode with 75 V laser power.
N-terminal Sequence Determination
The purified protein (500 pmol) was dissolved in ACN 37% to determine the
N-terminus sequence as described by da Silva et al. [26]. Briefly, this was processed with Edman degradation
using a PPSQ-21A Protein Sequencer following the manufacturer’s instructions and
protocols (Shimadzu, Japan). The N-terminal sequence was analyzed with the
Expert Protein Analysis System (http://www.expasy.org/) and the Blast platform
was adopted to perform the sequence search
(). The sequences
alignments were performed with ClustalW (http://www.ebi.ac.uk/clustalw/).
Phospholipase A2 Activity
The purified Mlx-8 toxin and crude venom were obtained from Micrurus
lemniscatus and were assayed for phospholipase A2
activity using 4-nitro-3 (octanoloxy) benzoic acid (NOBA) as the substrate
[32]. Different protein
concentrations in 20 µL of 150 mM NaCl were incubated with 20 µL of 3 mM NOBA in
acetonitrile and 100 µL of a buffer containing 10 mM Tris, 10 mM
CaCl2, and 100 mM NaCl, pH 8. Plates were incubated for 30, 40,
and 60 min at 37°C, and absorbance was recorded at 425 nm using a Spectra Max
190 plate reader (Molecular Devices, USA) after addition of 20 µL of 2.5% Triton
X-100. The results were expressed as mmol/min/mg of protein of one experiment
performed in triplicate.In another series of experiments, 200 μM DEDA, a PLA2 inhibitor, was
incubated in the presence of 2.8 μg Mlx-8 for 60 min and the phospholipase
A2 activity was determined as described above.
The hippocampus membrane was collected from six animals per experiment and was
prepared as described previously [33].
Briefly, the hippocampi were isolated from rats, minced, and homogenized in 25
mM Tris-HCl, pH 7.4 (containing 0.3 M sucrose, 5 mM MgCl2, 1 mM EDTA,
and 1 mM phenylmethylsulfonyl fluoride) with a Ultra-Turrax homogenizer (T-25,
Ika Labortechnik, Staufen, Germany). The homogenate was centrifuged at 1,000 × g
for 10 min. The supernatant was then filtered through two layers of gauze and
centrifuged at 100,000 × g for 60 min. The final 100,000 × g pellet was
re-suspended in 1 mL of 25 mM Tris-HCl, pH 7.4 (containing 5 mM
MgCl2, 1 mM EDTA, and 1 mM phenylmethylsulfonyl fluoride) using a
Dounce homogenizer and stored at -80oC. All procedures were performed
at 4oC, and all solutions contained freshly added 1 mM
phenylmethylsulfonyl fluoride to inhibit proteolysis. The total protein
concentration in the membrane preparations was determined with a protein reagent
assay (Bio Rad Laboratories Inc., USA).Competition binding experiments were performed as previously described [34]. Briefly, the hippocampus membrane
solution (80 µg protein/mL) was incubated with [3H]QNB (concentration
near the KD values) [33] for 1
h at 30oC in the absence and presence of increasing concentrations of
Mlx-8 toxin or muscarinic antagonist pirenzepine (control). In another series of
experiments, 1 μM Mlx-8 toxin was incubated with [3H]QNB in the
absence or presence of 200 μM DEDA [27,
35, 36] as described above.Competition binding data were analyzed using a weighted nonlinear least-squares
interactive curve-fitting program GraphPad Prism (GraphPad Prism Software Inc,
USA). A mathematical model for one or two binding sites was applied. The
inhibition constant (Ki) was determined from competition curves using
the Cheng and Prusoff equation [37]. The
potency of the antagonist was expressed via the negative logarithm of their
Ki value (pKi).
Measurement of Total [3H]inositol Phosphate
Hippocampi were isolated from rats and washed with a nutrient solution of the
following composition (mM): NaCl 118.00; KCl 4.78; CaCl2 2.43;
MgSO4 1.16; NaHCO3 23.80; KH2PO4
1.17; and glucose 2.92 (pH 7.4). Hippocampus slices (100 mg of tissue) were
allowed to equilibrate for 10 min in nutrient solution at 37oC under
constant shaking. The slices were incubated for 40 min with 1 µCi
myo-[3H]inositol and for an additional 30 min with 10 mM lithium
chloride with myo-[3H]inositol. Tissues were then incubated in the
absence (basal level) or presence of carbachol (CCh, 10-8 to
10-3 M) for 40 min. Mlx-8 toxin (10-7 and
10-6 M) was added 5 min prior to incubation with CCh
(10-5 M). Tissues were washed three times with nutrient solution,
transferred to 2 mL of methanol:chloroform (2:1 v/v) at 4oC, and
homogenized with a Ultra-Turrax T25 homogenizer at 9,500 rpm. Chloroform (0.62
mL) and H2O (0.93 mL) were added to the homogenate, and the solution
was centrifuged for 10 min at 2,000 x g and 4oC to separate the
aqueous and organic phases [38, 39].Total [3H]inositol phosphate was measured as previously described
[40] with the following modification:
the aqueous layer was mixed with 1 mL anion-exchange resin (Dowex AG-X8, formate
form, 200-400 mesh) allowed to equilibrate for 30 min at room temperature. It
was then centrifuged at 1,000 × g for 5 min at 4oC. The resin was
sequentially washed with myo-inositol (4 mL) and 5 mM sodium tetraborate/60 mM
sodium formate (2 mL). Subsequently, the resin was incubated for 30 min at room
temperature with 2 mL of 0.1M formic acid/1M ammonium formate. The total
[3H]inositol phosphate was eluted and placed in scintillation
vials containing OptiPhase HiSafe 3. The amount of radioactivity was determined
in a scintillation β-counter (LS 6500 IC, Beckman). Total
[3H]inositol phosphate was expressed as dpm/mg tissue.
Statistical Analysis
Data were expressed as the mean ± S.E.M. Data were analyzed by ANOVA followed by
Newman-Keuls test for multiple comparisons or via a two-tailed Student’s
t-test to compare a response between the two groups [41]. P values < 0.05 were considered to
be significant.
Results
Biochemical Characterization of the Mlx-8 Toxin
Figure 1 presents the RP-HPLC profile of
the Micrurus lemniscatus venom. The fraction that contains the
Mlx-8 was purified in a C18 RP-HPLC column (Fig.
2A): 180 µg of Mlx-8 toxin was obtained from 30 mg of the crude
venom. Mlx-8 toxin was collected and had its molecular mass verified by
MALDI-TOF. The MS profile was 13,628 as shown for the peak in Figure 2B.
Figure 1
Crude venom purified on high performance liquid chromatography
(HPLC) using a C8 column on a Prominence binary system (Shimadzu).
The venom components were eluted with a flow rate of 1 mL/min with
solvents A [0.1% trifluoroacetic acid (TFA) in deionized
H2O] and B (90% acetonitrile, 0.1% TFA in deionized
H2O) with gradient from 10 to 35% of solution B,
represented by the trace. The absorbance was read at 214 nm. In the
highlighted area, the arrow indicates the fraction that contains the
Mlx-8 with a retention time of 61 minutes in 75 minutes run.
Figure 2
(A) The fraction that contains the Mlx-8 was
purified on HPLC-RF using a C18 column eluted under a flow rate of 1
mL/min with solvents A and B from 0 to 100% acetonitrile in 0.1% TFA
aqueous solution represented by the trace. The absorbance was read
at 214 nm. Only the highest peak was collected, thus removing the
contaminants from the sample and guaranteeing its purity.
(B) Mass spectrum of the Mlx-8 toxin obtained via
mass spectrometry technique in MALDI-TOF ionization mode. The toxin
was analyzed using the saturated sinapinic acid matrix solution (1:1
v/v) and deposited directly onto MCP AnchorChip 600/384 plates. This
was co-crystallized at room temperature. After ionization, the Mlx-8
toxin molecules were transformed into ions and counted by the
detector as a function of their mass/charge (m/z) and their
molecular mass was identified.
The Mlx-8 N-terminal sequence was determined by Edman degradation and the
following sequence: NLYQFKNMIQCTNTRSWLDFADYGCYCGRGGSGT (Fig. 3) was obtained. The sequence determination showed that
the Mlx-8 presents high similarity to other toxins from Elapidae such as the
PLA2 from Micrurus lemniscatus carvalhoi [9] and from Lemnitoxin from Micrurus
lemniscatus [31]. In
addition, this sequence was analyzed against the public protein data bank to
check for similarities with known proteins. Besides that, matches were
identified with toxins from Naja kaouthia, N.
sagittifera, N. atra, N.
sputatrix, M. tener, Pseudechis australis, P.
papuanus and M. nigrocintus venoms (Fig. 3).
Figure 3
Amino acid multiple sequence alignment. The Mlx-8 toxin obtained
from Micrurus lemniscatus venom was aligned with
other PLA2 from Micrurus lemniscatus carvalhoi
[9] and from Lemnitoxin
from Micrurus lemniscatus [31]. In addition, this sequence was analyzed
against the public protein data bank to check for similarities with
known proteins. Besides that, matches were identified with toxins
from Naja Kaouthia, N.
sagittifera, N. atra, N.
sputatrix, M. tener,
Pseudechis australis, P.
papuanus and M. nigrocintus venoms.
Phospolipase A2 Activity of the Mlx-8 Toxin
The phospholipase A2 enzymatic activity of 2.8 μg Mlx-8 toxin was
determined at different time periods (30, 40 and 60 minutes). The Mlx-8 could
hydrolyze the substrate to phospholipase A2, 4-NOBA at all times. The
60-minute time point revealed a greater activity (229.4 ± 14.33, 345.5 ± 9.12,
and 582.8 ± 29.3 mmol/min/mg, respectively, 30, 40 and 60 minutes).The amount of 2.8 μg Mlx-8 in the presence of 200 μM DEDA for 60 min decreased
51% (285.57 ± 7.47 mmol/min/mg) the phospholipase A2 enzymatic
activity.
Effect of Mlx-8 Toxin on [3H]QNB Binding in Hippocampus
Membranes
Figure 4A shows the displacement curves of
[3H]QNB bound to hippocampus membranes induced by Mlx-8 toxin and
pirezenpine (M1 selective antagonist) [42]. Analysis of the displacement curves induced by Mlx-8
toxin and pirenzepine indicated a statistical preference for a one-site rather
than a two-site fit (F-test, GraphPad Prism program). The
pKi values obtained from the analysis of Mlx-8 and antagonist
displacement curves via one-site fit and their respective Hill slopes
(nH) were 7.32 ± 0.15, n = 4 (nH = 1.14 ± 0.13) and
5.84 ± 0.18, n = 4 (nH = 0.94 ± 0.15) for Mlx-8 and pirenzepine,
respectively.
Figure 4
(A) Displacement curves of [3H]QNB bound
to hippocampus membranes from male rats induced by Mlx-8 toxin (⯀)
and muscarinic acetylcholine receptor antagonist pirezenpine (●).
(B) Displacement of [3H]QNB bound to
hippocampus membrane by 1 µM Mlx-8 toxin obtained from
Micrurus lemniscatus venom in the absence and
presence of 200 µM DEDA, an inhibitor of phospholipase A2. The data
are plotted as percentages of the binding in the absence of Mlx-8 or
muscarinic acetylcholine receptor antagonists. Each point and
vertical line represents the mean ± S.E.M. of n = 4, performed in
duplicate. Different letters indicate statistical significance (p
< 0.05; ANOVA, Newman–Keuls test).
The 200 µM DEDA had no effect on the inhibition of [3H]QNB binding in
hippocampus membranes when using 1 µM Mlx-8 (Fig.
4B).
Effects of Carbachol and Mlx-8 Toxin on total [3H]inositol
Phosphate Accumulation
The basal level of the total [3H]inositol phosphate in rat hippocampus
was 69.12 ± 5.80 dpm/mg tissue, n = 12. The cholinergic agonist carbachol (CCh,
10-8 M to 10-3 M) caused a concentration-dependent
increase in the hippocampal total [3H]inositol phosphate accumulation
(Fig. 5A). The maximum total
[3H]inositol phosphate accumulation was obtained with
10-5 M CCh (38.80 ± 4.50% above basal, n = 4) (Fig. 5A).
Figure 5
(A) Concentration-effect curve of carbachol (CCh) on
total [3H]inositol phosphate accumulation. (B)
Effect of the Mlx-8 toxin on total [3H]inositol phosphate
accumulation induced by 10-5 M CCh in the hippocampi from
male rats. Each point and vertical line represent the mean ± S.E.M.
of n = 3. Different letters indicate statistical significance (p
< 0.05; ANOVA, Newman-Keuls test).
The purified Mlx-8 toxin (10-7 and 10-6 M) obtained from
Micrurus lemniscatus snake venom did alter the total
[3H]inositol phosphate accumulation induced by 10-5 M
CCh in a concentration-dependent manner. The Mlx-8 toxin caused a blockade of
43.31 ± 8.86% (n = 3) and 97.42 ± 2.02% (n = 3) at 10-7 and
10-6 M, respectively, on [3H]inositol phosphate
accumulation induced by 10-5 M CCh in the rat hippocampus (Fig. 5B). In the absence of CCh, the Mlx-8
toxin (10-6 M) did not alter the total [3H]inositol
phosphate accumulation in the hippocampus (Fig.
5B) (p < 0.05; ANOVA, Newman-Keuls test).
Discussion
The results show for the first time that the mAChRs function is drastically affected
by Mlx-8 toxin, a muscarinic ligand with phospholipase A2 activity
obtained from Micrurus lemniscatus venom. This species is in the
Elapidae family, and its toxin can inhibit binding of the selective muscarinic
ligand [3H]QNB in rat membranes from the hippocampus. Furthermore, the
toxin also inhibited [3H]inositol phosphate accumulation in the
hippocampus.Muscarinic toxins that affect ligand binding to mAChR have been isolated from mamba
venom [see 43-45, for review]. The structures of this group of toxins are somewhat
similar to the postsynaptic neurotoxins and consist of three polypeptide loops
(3FTx). They all share roughly the same number of amino acids (63-66 AA) and
molecular weight (about 7 kDa). However, the molecular mass of Mlx-8 (13.6 kDa) from
the venom of Micrurus lemniscatus seen here is clearly different
from muscarinic toxins. In this way, a similar molecular mass of Mlx-8 was observed
versus muscarinic toxins with phospholipase A2 activity obtained from
Naja naja sputatrix (13.6 kDa) [27] and Naja atra (13.3 kDa) [29]. This indicates that Mlx-8 may belong to a group of snake
PLA2-toxins.Indeed, when N-terminal analysis and alignment of Mlx-8
(NLYQFKNMIQCTNTRSWL-DFADYG-CYCGRGGSGT) was determined and compared to other proteins
with muscarinic activity, the data revealed a high similarity to Elapidae venom
proteins including a neural phospholipase A2 muscarinic inhibitor from
Naja naja sputatrix (NLYQFKNMIQCTVPNR) [27] and Naja atra (NLYQFKNMIQCTVPSR) [29]. Recently, a toxin named Lemnitoxin was
isolated from Micrurus lemniscatus venom and shown to be a
PLA2 with myotoxic and pro-inflammatory activity [31]. The N-terminal comparison of the Mlx-8
toxin with Lemnitoxin (NLYQFKNMIQCTNTRSWL-DFADYG-CYCGYGGSGT) revealed an almost
identical amino acid sequence between both toxins suggesting either a very similar
toxin or an isoform. Other studies are needed to prove this issue. The Mlx-8 toxin
was strongly expected to have phospholipase A2 activity in view of the
biochemical properties described above. In fact, Mlx-8 shows phospholipase
A2 enzymatic activity.The mAChRs mediate a wide range of functions of the parasympathetic nervous system
both centrally and peripherally. Different experimental approaches have shown that
mAChRs are present in all organs, tissues, or cell types [see 46, for review]. The muscarinic actions of acetylcholine are
mediated by five distinct mAChR subtypes (M1 to M5) [47-49].
The M1, M3, and M5 subtypes couple primarily to
phospholipase C-mediated phosphoinositide hydrolysis. On the other hand, the
M2 and M4 subtypes couple primarily to adenylyl cyclase
inhibition [see 50, for review]. To
characterize the effect of Mlx-8 toxin on mAChRs at the protein level, Mlx-8 and the
M1 selective muscarinic antagonist pirenzepine were examined for
their ability to compete with [3H]QNB for binding sites in the
hippocampus membrane. The pKi of the Mlx-8 (7.32) was higher than that
obtained by pirenzepine (5.84). Moreover, the Hill slope coefficients calculated for
Mlx-8 and pirenzepine did not differ from unity. These data support the idea that
Mlx-8 has affinity for mAChRs. Further experimental approaches are needed to clarify
the mechanisms involved and the functional significance of Mlx-8 on mAChRs.This study focused only on the phospholipase C-mediated phosphoinositide hydrolysis
in hippocampal tissue because the population of M1 receptors is
predominant in the rat hippocampus [see 46,
for review]. The Mlx-8 toxin obtained from Micrurus lemniscatus
venom reduced the response to carbachol on total [3H]inositol phosphate
accumulation in a concentration-dependent manner. In the absence of carbachol, 1 µM
Mlx-8 did not alter the level of total [3H]inositol phosphate. These
studies collectively indicate that the Mlx-8 toxin blocked the intracellular
signaling pathway linked to activation of mAChRs in rat hippocampus. Interestingly,
the Mlx-8 toxin is quite different from the toxin obtained from Naja
atra venom [29]. Although both
exhibit similarity of the N-terminal amino acid sequence and molecular mass, Mlx-8
(1 µM) inhibits the total [3H]inositol phosphate accumulation (97%)
induced by muscarinic agonist carbachol while the Naja atra venom
promotes contraction in the ileum of guinea pig via mAChRs [29]. Whether the Mlx-8 toxin plays a role in other
intracellular signaling pathways coupled to mAChRs remains to be explored.Specific binding membrane receptor proteins of venom phospholipase A2 have
been shown. For example, vipoxin (a minor PLA2 from Vipera
russelli venom) can bind to amine receptors on rat brain [51]. OS2 is a single-chain PLA2
isolated from Oxyuranus scutellatus venom and associates
selectively with rat brain membrane proteins termed N-type receptors [52]. Moreover, there is evidence suggesting
that the ability to interact with nicotinic acetylcholine receptors may be a general
property of several snakes PLA2 from venoms [53, 54]. To check the
ability of the PLA2 isolated from Micrurus lemniscatus
(Mlx-8) to interact with mAChRs, the inhibitor of cobra venom phospholipases
A2 activity DEDA, an analogue of arachidonic acid that contains two
cis double bonds as well as two methyl groups [55], was used in the present study. Indeed, the phospholipase
A2 enzymatic activity of Mlx-8 in the presence of DEDA decreased 51%.
Interestingly, there was no impact on inhibition of [3H]QNB binding in
hippocampus membranes via DEDA, suggesting that the inhibition of the phospholipase
A2 activity of the venom did not alter its ability to bind and
displace [3H]QNB binding. Similarly, DEDA did not also block the mAChRs
binding in muscarinic toxin with PLA2 activity obtained from Naja
naja sputatrix venom [27]. On
the other hand, the inhibitor of phospholipases A2 activity
p-bromophenacyl bromide, which modifies the histidine residue in the active site of
PLA2, eliminated both PLA2 activity and [3H]QNB
binding [27]. Thus, only DEDA showed no
effect on mAChRs binding when used [28].Micrurus venoms are natural libraries of biologically active
molecules that can be used as new drug leads. However, a major obstacle to
characterize the components of Micrurus venoms is the minute
quantities of material obtained from specimen milking. Thus, despite the large
variety of molecules with potential biotechnological application, there is still a
great difficulty of their bioprospecting due to the small amount of starting
material, low yield and the high cost of traditional purification strategies. In
general, this alone explains the small number of animal molecules currently used as
drugs. The recent development and use of “omic” tools has become increasingly
prominent since they allow an overview of the composition of the venom. In addition,
the transcriptome technique, associated with the cloning and heterologous expression
of proteins and peptides, enables the production of molecules present in the gland
or specialized tissue in sufficient quantity for their structural and functional
analysis. Therefore, these studies enable the application of molecules with relevant
biological activity. From this perspective, as regards Mlx-8, further studies will
be required to better explore the biological potential of this toxin.
Conclusion
The results of the present work show, for the first time, that mAChRs are also
affected by the Mlx-8 toxin, a muscarinic ligand with phospholipase A2
characteristics, obtained from the venom of the Elapidae snake Micrurus
lemniscatus, since this toxin was able to compete with muscarinic
ligand [3H]QNB in hippocampus from rats. In addition, Mlx-8 also
blocked the accumulation of total [3H]inositol phosphate induced by
muscarinic agonist carbachol. Thus, Mlx-8 may be a new pharmacological tool for
examining muscarinic cholinergic function.
Authors: Ekaterina N Lyukmanova; Zakhar O Shenkarev; Mikhail A Shulepko; Alexander S Paramonov; Anton O Chugunov; Helena Janickova; Eva Dolejsi; Vladimir Dolezal; Yuri N Utkin; Victor I Tsetlin; Alexander S Arseniev; Roman G Efremov; Dmitry A Dolgikh; Mikhail P Kirpichnikov Journal: J Biol Chem Date: 2015-08-04 Impact factor: 5.157
Authors: Rafael S Floriano; Raphael Schezaro-Ramos; Nelson J Silva; Fábio Bucaretchi; Edward G Rowan; Stephen Hyslop Journal: Arch Toxicol Date: 2019-05-23 Impact factor: 5.153
Authors: D A Oliveira; C Harasawa; C S Seibert; L L Casais e Silva; D C Pimenta; I Lebrun; M R L Sandoval Journal: Brain Res Bull Date: 2007-11-20 Impact factor: 4.077